Publications

  1. Pleyer C, Bittner H, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Herrick LM, Talley NJ. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol Motil. 2014 Aug; 26(8):1163-71. Epub 2014 Jun 11.
    View PubMed
  2. Halland M, Almazar A, Lee R, Atkinson E, Larson J, Talley NJ, Saito YA. A case-control study of childhood trauma in the development of irritable bowel syndrome. Neurogastroenterol Motil. 2014 Jul; 26(7):990-8. Epub 2014 May 11.
    View PubMed
  3. Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014 Jun; 146(7):1659-68. Epub 2014 Mar 05.
    View PubMed
  4. Gupta M, Beebe TJ, Dunagan KT, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd, Iyer PG. Screening for Barrett's Esophagus: Results from a Population-Based Survey. Dig Dis Sci. 2014 Mar 21.
    View PubMed
  5. Choung RS, Locke GR 3rd, Francis DD, Katzka D, Winkle PJ, Orr WC, Crowell MD, Devault K, Harmsen WS, Zinsmeister AR, Talley NJ. Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study. Neurogastroenterol Motil. 2014 Jan; 26(1):13-20. Epub 2013 Sep 3
    View PubMed
  6. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population-based study. Aliment Pharmacol Ther. 2014 Jan; 39(2):217-25. Epub 2013 Dec 4
    View PubMed
  7. Talley NJ, Napthali KE. Endoscopy in symptomatic gastroesophageal reflux disease: Scoping out whomto target. JAMA Internal Medicine. 2014; 174(3):465-6.
  8. Guerin A, Mody R, Fok B, Lasch KL, Zhou Z, Wu EQ, Zhou W, Talley NJ. Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther. 2014; 40(1):83-92.
  9. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, Devault KR, Talley NJ, Achem SR. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013 Nov; 38(10):1312-9. Epub 2013 Oct 05.
    View PubMed
  10. Ludvigsson JF, Aro P, Walker MM, Vieth M, Agreus L, Talley NJ, Murray JA, Ronkainen J. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol. 2013 Jul; 48(7):808-14. Epub 2013 May 14.
    View PubMed
  11. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil. 2013 May; 25(5):413-9, e298. Epub 2013 Jan 29.
    View PubMed
  12. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):145-50.e1. Epub 2012 Oct 09.
    View PubMed
  13. Leggett CL, Nelsen EM, Tian J, Schleck CB, Zinsmeister AR, Dunagan KT, Locke GR 3rd, Wang KK, Talley NJ, Iyer PG. Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study. Mayo Clin Proc. 2013 Feb; 88(2):157-65.
    View PubMed
  14. Flook NW, Moayyedi P, Dent J, Talley NJ, Persson T, Karlson BW, Ruth M. Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2013 Jan; 108(1):56-64. Epub 2012 Nov 13.
    View PubMed
  15. Choung RS, Locke GR III, Schleck CD, Ziegenfuss JY, Beebe TJ, Zinsmeister AR, Talley NJ. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: A population-based study. Journal of Public Health (Germany). 2013; 21(1):87-95.
  16. Rajan E, Gostout CJ, Aimore Bonin E, Moran EA, Locke RG, Szarka LA, Talley NJ, Deters JL, Miller CA, Knipschield MA, Lurken MS, Stoltz GJ, Bernard CE, Grover M, Farrugia G. Endoscopic full-thickness biopsy of the gastric wall with defect closure by using an endoscopic suturing device: survival porcine study. Gastrointest Endosc. 2012 Nov; 76(5):1014-9.
    View PubMed
  17. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012 Oct; 57(10):2650-7. Epub 2012 Aug 02.
    View PubMed
  18. Talley NJ. Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol (N Y). 2012 Aug; 8(8):552-4.
    View PubMed
  19. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46. Epub 2012 Apr 24.
    View PubMed
  20. Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):742-749.e1. Epub 2012 Apr 01.
    View PubMed
  21. Myasoedova E, Matteson EL, Talley NJ, Crowson CS. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol. 2012 Jul; 39(7):1355-62. Epub 2012 Apr 01.
    View PubMed
  22. Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. Epub 2012 May 16.
    View PubMed
  23. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012 May; 10(5):481-6. Epub 2012 Feb 3.
    View PubMed
  24. Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33. Epub 2012 Feb 10.
    View PubMed
  25. Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 2012 May; 10(5):494-500. Epub 2012 Jan 28.
    View PubMed
  26. Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Challenges and lessons learned in conducting comparative-effectiveness trials. Am J Gastroenterol. 2012 May; 107(5):644-9.
    View PubMed
  27. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian-Sararoudi R, Daghaghzadeh H, Soltanian N, Feinle-Bisset C, Boyce P, Talley NJ. The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. Journal Of Research In Medical Sciences. 2012 Mar; 17:S292-8.
  28. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012 Mar; 24(3):229-34, e106. Epub 2011 Dec 12.
    View PubMed
  29. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012 Jan; 107(1):82-8. Epub 2011 Nov 15.
    View PubMed
  30. Choung RS, Locke GR 3rd, Lee RM, Schleck CD, Zinsmeister AR, Talley NJ. Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males. Neurogastroenterol Motil. 2012 Jan; 24(1):20-6, e1. Epub 2011 Sep 27.
    View PubMed
  31. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd. Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil. 2012 Jan; 18(1):34-42. Epub 2012 Jan 16.
    View PubMed
  32. Brook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ. Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population. Dig Dis Sci. 2012 Jan; 57(1):109-18. Epub 2011 Jul 13
    View PubMed
  33. Tack J, Talley NJ. [In process citation]. Arq Gastroenterol. 2012; 49 Suppl 1:21-7.
    View PubMed
  34. Chang JY, Talley NJ, Locke GR 3rd, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Wu TT, Wang KK, Prasad GA. Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc. 2011 Dec; 86(12):1174-80.
    View PubMed
  35. van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E, STARS II Investigators. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther. 2011 Oct; 34(7):714-23. Epub 2011 Aug 17.
    View PubMed
  36. Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract. 2011 Sep 15; 207(9):538-44. Epub 2011 Sep 22.
    View PubMed
  37. Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wu TT, Wang KK, Frederickson M, Geno DM, Locke GR, Prasad GA. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol. 2011 Aug; 106(8):1447-55; quiz 1456. Epub 2011 Apr 12.
    View PubMed
  38. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, Arora AS, Alexander JA. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci. 2011 Jul; 56(7):1981-6. Epub 2011 Feb 06.
    View PubMed
  39. Katz KD, Rashtak S, Lahr BD, Melton LJ 3rd, Krause PK, Maggi K, Talley NJ, Murray JA. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011 Jul; 106(7):1333-9. Epub 2011 Mar 01.
    View PubMed
  40. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2011 Jun; 51(6):341-7.
  41. Achem SR, Almansa C, Krishna M, Heckman MG, Wolfsen HC, Talley NJ, DeVault KR. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011 Jun; 33(11):1194-201. Epub 2011 Apr 05.
    View PubMed
  42. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 May; 33(9):1059-67. Epub 2011 Mar 13.
    View PubMed
  43. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56(5):1452-9. Epub 2010 Dec 23.
    View PubMed
  44. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26.
    View PubMed
  45. Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):601-16. Epub 2011 Mar 15.
    View PubMed
  46. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):617-29. Epub 2011 Mar 15.
    View PubMed
  47. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
  48. Beebe TJ, Ziegenfuss JY, St Sauver JL, Jenkins SM, Haas L, Davern ME, Talley NJ. Health Insurance Portability and Accountability Act (HIPAA) authorization and survey nonresponse bias. Med Care. 2011 Apr; 49(4):365-70.
    View PubMed
  49. Dinning PG, Jones M, Hunt L, Fuentealba SE, Kalanter J, King DW, Lubowski DZ, Talley NJ, Cook IJ. Factor analysis identifies subgroups of constipation. World J Gastroenterol. 2011 Mar 21; 17(11):1468-74.
    View PubMed
  50. Ang D, Talley NJ, Simren M, Janssen P, Boeckxstaens G, Tack J. Review article: endpoints used in functional dyspepsia drug therapy trials. Aliment Pharmacol Ther. 2011 Mar; 33(6):634-49. Epub 2011 Jan 12.
    View PubMed
  51. Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, Bonis PA. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):300-6.
    View PubMed
  52. Talley NJ. Rumination syndrome. Gastroenterol Hepatol (N Y). 2011 Feb; 7(2):117-8.
    View PubMed
  53. Choung RS, Branda ME, Chitkara D, Shah ND, Katusic SK, Locke GR 3rd, Talley NJ. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther. 2011 Jan; 33(2):251-60. Epub 2010 Nov 22.
    View PubMed
  54. Chang JY, Talley NJ. An update on irritable bowel syndrome: from diagnosis to emerging therapies. Curr Opin Gastroenterol. 2011 Jan; 27(1):72-8.
    View PubMed
  55. Choung RS, Shah ND, Chitkara D, Branda ME, Van Tilburg MA, Whitehead WE, Katusic SK, Locke GR 3rd, Talley NJ. Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study. J Pediatr Gastroenterol Nutr. 2011 Jan; 52(1):47-54.
    View PubMed
  56. Jung KW, Gundersen N, Kopacova J, Arora AS, Romero Y, Katzka D, Francis D, Schreiber J, Dierkhising RA, Talley NJ, Smyrk TC, Alexander JA. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011 Jan; 73(1):15-21. Epub 2010 Nov 09.
    View PubMed
  57. Myasoedova E, Talley NJ, Manek NJ, Crowson CS. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota. Gastroenterol Res Pract. 2011; 2011:745829. Epub 2011 Nov 17.
    View PubMed
  58. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105(12):2525-9.
    View PubMed
  59. Choung RS, Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol. 2010 Nov-Dec; 44(10):696-701.
    View PubMed
  60. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, Bolling-Sternevald E, Bolinder G, Alving K, Talley NJ, Agreus L. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010 Oct; 25(10):741-50. Epub 2010 Jul 29.
    View PubMed
  61. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, Talley NJ, Diehl NN, Beebe TJ, Harris AM, Farrugia G, Graner DE, Murray JA, Locke GR 3rd, Grothe RM, Crowell MD, Francis DL, Grudell AM, The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010 Sep; 25(3):221-30. Epub 2009 Oct 24.
    View PubMed
  62. Chang JY, Choung RS, Lee RM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):669-75; quiz e88. Epub 2010 May 06.
    View PubMed
  63. Walker MM, Murray JA, Ronkainen J, Aro P, Storskrubb T, D'Amato M, Lahr B, Talley NJ, Agreus L. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology. 2010 Jul; 139(1):112-9. Epub 2010 Apr 13.
    View PubMed
  64. Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010 Jul; 31(7):326-34. Epub 2010 Jun 01.
    View PubMed
  65. Rey E, Locke GR 3rd, Jung HK, Malhotra A, Choung RS, Beebe TJ, Schleck CD, Zinsmeister AR, Talley NJ. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Ther. 2010 Jun; 31(11):1237-47. Epub 2010 Mar 06.
    View PubMed
  66. Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010 Jun; 31(11):1229-36. Epub 2010 Mar 04.
    View PubMed
  67. Gururatsakul M, Holloway RH, Talley NJ, Holtmann GJ. Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction. J Gastroenterol Hepatol. 2010 Jun; 25(6):1162-9.
    View PubMed
  68. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):498-503. Epub 2010 Mar 19.
    View PubMed
  69. Walter SA, Kjellstrom L, Nyhlin H, Talley NJ, Agreus L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010 May; 45(5):556-66.
    View PubMed
  70. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR 3rd, Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr; 105(4):833-41. Epub 2010 Mar 16.
    View PubMed
  71. Tack J, Talley NJ. Gastroduodenal disorders. Am J Gastroenterol. 2010 Apr; 105(4):757-63.
    View PubMed
  72. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010 Apr; 8(4):344-349.e3. Epub 2010 Jan 06.
    View PubMed
  73. Leise MD, Locke GR 3rd, Dierkhising RA, Zinsmeister AR, Reeder GS, Talley NJ. Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization. Mayo Clin Proc. 2010 Apr; 85(4):323-30. Epub 2010 Mar 01.
    View PubMed
  74. Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010 Apr; 105(4):822-32. Epub 2010 Feb 16.
    View PubMed
  75. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010 Mar; 105(3):652-61. Epub 2009 Oct 27.
    View PubMed
  76. Gururatsakul M, Holloway RH, Adam B, Liebregts T, Talley NJ, Holtmann GJ. The ageing gut: diminished symptom response to a standardized nutrient stimulus. Neurogastroenterol Motil. 2010 Mar; 22(3):246-e77. Epub 2009 Oct 08.
    View PubMed
  77. Haag S, Senf W, Tagay S, Heuft G, Gerken G, Talley NJ, Holtmann G. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil. 2010 Mar; 22(3):262-e79. Epub 2009 Oct 08.
    View PubMed
  78. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010 Mar; 7(3):146-56. Epub 2010 Feb 02.
    View PubMed
  79. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010 Mar; 59(3):325-32. Epub 2008 Dec 17.
    View PubMed
  80. Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2010 Feb; 105(2):298-307. Epub 2009 Nov 03.
    View PubMed
  81. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol. 2010 Feb; 105(2):412-9. Epub 2009 Oct 20.
    View PubMed
  82. Ford AC, Guyatt GH, Talley NJ, Moayyedi P. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol. 2010 Feb; 105(2):280-8. Epub 2009 Nov 17.
    View PubMed
  83. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. "Associations among binge eating behavior patterns and gastrointestinal symptoms: A population-based study": Corrigendum. Int J Obes. 2010 Jan; 34(1):214.
  84. Zhang L, Eslick GD, Xia HH, Wu C, Phung N, Talley NJ. Relationship between alcohol consumption and active Helicobacter pylori infection. Alcohol Alcohol. 2010 Jan-Feb; 45(1):89-94. Epub 2009 Oct 06.
    View PubMed
  85. Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol. 2010 Jan; 105(1):170-7. Epub 2009 Oct 06.
    View PubMed
  86. Jung HK, Choung RS, Talley NJ. Response to Dr Tursi. Am J Gastroenterol. 2010; 105(10):2293-4.
  87. Beebe TJ, Rey E, Ziegenfuss JY, Jenkins S, Lackore K, Talley NJ, Locke RG 3rd. Shortening a survey and using alternative forms of prenotification: impact on response rate and quality. BMC Med Res Methodol. 2010; 10:50. Epub 2010 Jun 08.
    View PubMed
  88. Talley NJ, Herrick L, Locke GR. Editorial: Antidepressants in functional dyspepsia. Expert rev. gastroenterol. Hepatol. 2010; 4(1):5-8.
    View PubMed
  89. Tack J, Talley NJ. Gastroduodenal disorders. Rev Gastroenterol Mex. 2010; 75(4):463-71.
  90. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1279-86. Epub 2009 Aug 12.
    View PubMed
  91. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:1-8.
    View PubMed
  92. Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:41-54.
    View PubMed
  93. Talley NJ. Response to mangel. Am J Gastroenterol. 2009 Dec; 104(12):3106.
    View PubMed
  94. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23.
    View PubMed
  95. Talley NJ. So you aspire to be a Professor? World J Gastroenterol. 2009 Nov 28; 15(44):5626-5627.
    View PubMed
  96. Eslick GD, Kalantar JS, Talley NJ. Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study. Colorectal Dis. 2009 Nov; 11(9):921-6. Epub 2008 Oct 21.
    View PubMed
  97. Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE. Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol. 2009 Nov-Dec; 43(10):933-40.
    View PubMed
  98. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009 Nov; 41(11):772-80. Epub 2009 Aug 08.
    View PubMed
  99. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009 Oct; 24(10):1587-600.
    View PubMed
  100. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol. 2009 Oct; 24 Suppl 3:S20-8.
    View PubMed
  101. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther. 2009 Oct; 30(7):775-83. Epub 2009 Jun 25.
    View PubMed
  102. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, Locke GR 3rd, Talley NJ. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009 Oct; 7(10):1055-61. Epub 2009 Jul 01.
    View PubMed
  103. Saito YA, Talley NJ. AJG series: molecular biology for clinicians. Am J Gastroenterol. 2009 Oct; 104(10):2583-7. Epub 2009 Jun 23.
    View PubMed
  104. Chang JY, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil. 2009 Oct; 21(10):1060-e87. Epub 2009 May 21.
    View PubMed
  105. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol. 2009 Sep; 6(9):524-32.
    View PubMed
  106. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02.
    View PubMed
  107. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Bjorck E, Lind T, Bolling-Sternevald E, STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):756-61. Epub 2009 Apr 10.
    View PubMed
  108. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009 Jul; 137(1):94-100. Epub 2009 Mar 26.
    View PubMed
  109. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009 Jul; 104(7):1772-9. Epub 2009 Jun 02.
    View PubMed
  110. Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol. 2009 Jun; 104(6):1339-41.
    View PubMed
  111. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009 May; 104(5):1199-204. Epub 2009 Apr 14.
    View PubMed
  112. Goodwin RD, Keyes KM, Stein MB, Talley NJ. Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med. 2009 May; 71(4):463-8.
    View PubMed
  113. Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr 1; 29(7):765-73. Epub 2009 Jan 17.
    View PubMed
  114. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 Apr; 136(4):1225-33. Epub 2008 Dec 24.
    View PubMed
  115. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Wolfsen H, Raimondo M, Guarderas JC, Achem SR. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009 Apr; 104(4):828-33. Epub 2009 Feb 24.
    View PubMed
  116. Talley NJ, Seon Choung R. Functional (non-ulcer) dyspepsia and gastroparesis--differentiating these conditions and practical management approaches. Rev Gastroenterol Disord. 2009 Spring; 9(2):E48-53.
    View PubMed
  117. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33(3):342-53. Epub 2009 Jan 13.
    View PubMed
  118. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296(2):G211-8. Epub 2008 Dec 04.
    View PubMed
  119. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009 Feb; 43(2):111-7.
    View PubMed
  120. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
  121. Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson ABR, Yeomans ND. Predictors of gastroduodenal erosions in patients taking low-dose aspirin. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):143-9.
    View PubMed
  122. Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol. 2009 Jan; 7(1):9-19. Epub 2008 Oct 01.
    View PubMed
  123. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009 Jan; 104 Suppl 1:S1-35.
    View PubMed
  124. Agreus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol. 2009; 44(5):564-70.
    View PubMed
  125. Rex DK, Talley NJ, Katz PO, Sandborn WJ, Hanauer SB. Report From the ACG: Highlights of the 72nd Annual Scientific Meeting of the American College of Gastroenterology, October 12-17, 2007, Philadelphia, PA. Rev Gastroenterol Disord. 2008 Winter; 8(1):42-57.
  126. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol. 2008 Nov 1; 102(9):1207-11. Epub 2008 Aug 27.
    View PubMed
  127. Talley NJ. Genetics and functional bowel disease. J Pediatr Gastroenterol Nutr. 2008 Nov; 47(5):680-2.
    View PubMed
  128. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut. 2008 Nov; 57(11):1545-53. Epub 2008 Aug 01.
    View PubMed
  129. Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scan J Gastroenterol. 2008 Nov:1-7.
  130. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA. 2008 Oct 15; 300(15):1793-805.
    View PubMed
  131. Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc. 2008 Oct; 83(10):1087-94.
    View PubMed
  132. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008 Oct; 103(10):2613-23. Epub 2008 Sep 04.
    View PubMed
  133. Talley NJ. Reply to Dr. Kittisupamongkol. Am J Gastroenterol. 2008 Sep 04. [Epub ahead of print]
    View PubMed
  134. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008 Sep; 20(9):989-97. Epub 2008 May 06.
    View PubMed
  135. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):888-97.
    View PubMed
  136. Talley NJ. RESPONSE TO THE LETTER. Am J Gastroenterol. 2008 Aug 27. [Epub ahead of print]
    View PubMed
  137. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther. 2008 Aug 1; 28(3):334-43.
    View PubMed
  138. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103(8):2043-50.
    View PubMed
  139. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008 Aug; 103(8):2100-4; quiz 2105. Epub 2008 Jul 05.
    View PubMed
  140. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol. 2008 Aug; 103(8):1906-19. Epub 2008 Jul 04.
    View PubMed
  141. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008 Aug; 103(8):2023-30.
    View PubMed
  142. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol. 2008 Aug; 103(8):2051-60.
    View PubMed
  143. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc. 2008 Aug; 68(2):301-7. Epub 2008 Feb 11.
    View PubMed
  144. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008 Jul; 20(7):790-7.
    View PubMed
  145. Shah ND, Chitkara DK, Locke GR, Meek PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol. 2008 Jul; 103(7):1746-53. Epub 2008 Jun 28.
    View PubMed
  146. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07.
    View PubMed
  147. Talley NJ. Chronic unexplained diarrhea: what to do when the initial workup is negative? Rev Gastroenterol Disord. 2008 Summer; 8(3):178-85.
    View PubMed
  148. Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008 Jun; 37(2):383-95, vi.
    View PubMed
  149. Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med. 2008 Jun; 8(4):253-7.
    View PubMed
  150. Prasad GA, Talley NJ. Eosinophilic esophagitis in adults. Gastroenterol Clin North Am. 2008 Jun; 37(2):349-68, v-vi.
    View PubMed
  151. Talley NJ. Gut eosinophilia in food allergy and systemic and autoimmune diseases. Gastroenterol Clin North Am. 2008 Jun; 37(2):307-32, v.
    View PubMed
  152. Talley NJ. Eosinophilic and autoimmune gastrointestinal disease: new insights and new entities. Preface. Gastroenterol Clin North Am. 2008 Jun; 37(2):xi-xii.
    View PubMed
  153. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008 Jun; 57(6):756-63.
    View PubMed
  154. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008 Jun; 57(6):740-6. Epub 2007 Oct 26.
    View PubMed
  155. Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguere M, Horowitz M, Jones KL. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil. 2008 May; 20(5):456-63. Epub 2008 Jan 07.
    View PubMed
  156. Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther. 2008 May; 27(10):971-9. Epub 2008 Feb 28.
    View PubMed
  157. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008 May; 103(5):1241-8. Epub 2008 Apr 16.
    View PubMed
  158. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May; 20 Suppl 1:121-9.
    View PubMed
  159. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: A population-based cohort study. Aliment Pharmacol Ther. 2008 Apr 13. [Epub ahead of print]
    View PubMed
  160. Haag S, Senf W, Hauser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008 Apr 1; 27(7):561-71. Epub 2008 Jan 16.
    View PubMed
  161. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18(4):401-7. Epub 2008 Feb 20.
    View PubMed
  162. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008 Apr; 103(4):820-2.
    View PubMed
  163. Talley NJ. Commentary: Controversies in NICE guidance on irritable bowel syndrome. BMJ. 2008 Mar 8; 336(7643):558-9.
    View PubMed
  164. Choung RS, Ferguson DD, Murray JA, Kammer PP, Dierkhising RA, Zinsmeister AR, Nurbhai S, Landau SB, Talley NJ. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. Aliment Pharmacol Ther. 2008 Mar 1; 27(5):404-11. Epub 2007 Dec 11.
    View PubMed
  165. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil. 2008 Mar; 20(3):220-7. Epub 2007 Nov 20.
    View PubMed
  166. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol. 2008 Mar; 103(3):510-4.
    View PubMed
  167. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008 Mar; 23(3):351-65.
    View PubMed
  168. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Feb 15; 27(4):316-20. Epub 2007 Dec 06.
    View PubMed
  169. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-Levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works? Gastrointest Endosc. 2008 Feb; 67(2):297-303. Epub 2007 Oct 29.
    View PubMed
  170. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol. 2008 Feb; 42(2):160-6.
    View PubMed
  171. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S, Lin SR, Wong BC, Chan FK, Rani AA, Bak YT, Sollano J, Ho KY, Manatsathit S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008 Jan; 23(1):8-22.
    View PubMed
  172. Talley NJ, Locke GR 3rd, McNally M, Schleck CD, Zinsmeister AR, Melton LJ 3rd. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol. 2008 Jan; 103(1):12-9. Epub 2007 Sep 26.
    View PubMed
  173. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci. 2008 Jan; 53(1):108-15. Epub 2007 May 15.
    View PubMed
  174. Tuteja AK, Talley NJ, Gelman SS, Alder SC, Thompson C, Tolman K, Hale DC. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci. 2008 Jan; 53(1):271-6. Epub 2007 Jun 05.
    View PubMed
  175. Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making. 2008 Jan-Feb; 28(1):44-55. Epub 2007 Dec 05.
    View PubMed
  176. Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, Moayyedi P. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008; 337:a2313. Epub 2008 Nov 13.
    View PubMed
  177. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, Agreus L. Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis. 2008; 26(3):256-63. Epub 2008 May 07.
    View PubMed
  178. Agreus L, Talley NJ, Sheen A, Johansson SE, Jones MP, Svardsudd K. Predictors and non-predictors of symptom relief in dyspepsia consultations in primary care. Dig Dis. 2008; 26(3):248-55. Epub 2008 May 07.
    View PubMed
  179. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, Agreus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol. 2008; 43(12):1448-55.
    View PubMed
  180. Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of dyspepsia: will it help research? Dig Dis. 2008; 26(3):203-9. Epub 2008 May 06.
    View PubMed
  181. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007 Dec; 102(12):2627-32. Epub 2007 Aug 31.
    View PubMed
  182. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1521-8. Epub 2007 Oct 05.
    View PubMed
  183. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007 Nov; 19(11):905-11.
    View PubMed
  184. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007 Nov; 23(4):721-34, v.
    View PubMed
  185. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Epidemiology of slow and fast colonic transit using a scale of stool form in a community. Aliment Pharmacol Ther. 2007 Oct 1; 26(7):1043-50.
    View PubMed
  186. Talley NJ, Li Z. Helicobacter pylori: testing and treatment. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):71-9.
    View PubMed
  187. Talley NJ. Introducing Expert Review of Gastroenterology and Hepatology. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):1-2.
    View PubMed
  188. Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd. The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care. 2007 Oct; 45(10):959-65.
    View PubMed
  189. Levy RL, Finch EA, Crowell MD, Talley NJ, Jeffery RW. Behavioral intervention for the treatment of obesity: strategies and effectiveness data. Am J Gastroenterol. 2007 Oct; 102(10):2314-21. Epub 2007 Jun 11.
    View PubMed
  190. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of Intestinal Metaplasia in Barrett's Esophagus. Am J Gastroenterol. 2007 Oct; 102(10):2353-4.
    View PubMed
  191. Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR, Agreus L. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1175-83. Epub 2007 Aug 07.
    View PubMed
  192. van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE, STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1; 26(5):665-72.
    View PubMed
  193. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Bjorck E, Lind T, STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther. 2007 Sep 1; 26(5):673-82.
    View PubMed
  194. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007 Sep; 133(3):799-807. Epub 2007 Jun 20.
    View PubMed
  195. Talley NJ. Functional nausea and vomiting. Aust Fam Physician. 2007 Sep; 36(9):694-7.
    View PubMed
  196. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007 Sep; 102(9):1983-9. Epub 2007 Jun 20.
    View PubMed
  197. Chitkara DK, Talley NJ, Locke GR 3rd, Weaver AL, Katusic SK, De Schepper H, Rucker MJ. Medical presentation of constipation from childhood to early adulthood: a population-based cohort study. Clin Gastroenterol Hepatol. 2007 Sep; 5(9):1059-64. Epub 2007 Jul 13.
    View PubMed
  198. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007 Aug 1; 26(3):453-61.
    View PubMed
  199. Halder SL, Talley NJ. Functional Dyspepsia: A New Rome III Paradigm. Curr Treat Options Gastroenterol. 2007 Aug; 10(4):259-72.
    View PubMed
  200. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol. 2007 Aug; 102(8):1596-602. Epub 2007 Apr 24.
    View PubMed
  201. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1; 25(11):1343-50.
    View PubMed
  202. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007 Jun; 102(6):1154-61. Epub 2007 Apr 13.
    View PubMed
  203. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jun; 19(6):465-70.
    View PubMed
  204. Cash BD, Chang E, Talley NJ, Wald A. Fresh perspectives in chronic constipation and other functional bowel disorders. Rev Gastroenterol Disord. 2007 Summer; 7(3):116-33.
    View PubMed
  205. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5(5):534-40. Epub 2007 Apr 11.
    View PubMed
  206. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007 May; 56(5):615-20.
    View PubMed
  207. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007 Apr 15; 25(8):973-86.
    View PubMed
  208. Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2007 Apr 1; 25(7):813-21.
    View PubMed
  209. McNally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastroenterol. 2007 Mar; 10(2):157-68.
    View PubMed
  210. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007 Mar; 132(3):913-20.
    View PubMed
  211. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007 Spring; 7(2):97-105.
    View PubMed
  212. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19(3):180-7.
    View PubMed
  213. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther. 2007 Feb 15; 25(4):447-53.
    View PubMed
  214. Richter JE, Talley NJ. American Journal of Gastroenterology 2006: The Best Clinical GI Journal in the World. Am J Gastroenterol. 2007 Feb; 102(2):229-31.
    View PubMed
  215. Chitkara DK, Talley NJ, Weaver AL, Katusic SK, De Schepper H, Rucker MJ, Locke GR 3rd. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):186-91.
    View PubMed
  216. Liebregts T, Adam B, Bertel A, Lackner C, Neumann J, Talley NJ, Gerken G, Holtmann G. Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain. 2007 Feb; 11(2):216-22.
    View PubMed
  217. Bueno L, De Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EMM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil. 2007 Jan; 19(Suppl 1):89-119.
    View PubMed
  218. Talley NJ. How to manage the difficult-to-treat dyspeptic patient. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan; 4(1):35-42.
    View PubMed
  219. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2007 Jan; 47(1):81-3, 87-8, 89-90.
    View PubMed
  220. Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Langstrom G, Naesdal J, Yeomans ND, NASA/SPACE author group. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther. 2007; 9(1):R17.
    View PubMed
  221. Grudell AB, Alexander JA, Enders FB, Pacifico R, Fredericksen M, Wise JL, Locke GR 3rd, Arora A, Zais T, Talley NJ, Romero Y. Validation of the Mayo Dysphagia Questionnaire. Dis Esophagus. 2007; 20(3):202-5.
    View PubMed
  222. Choung RS, Talley NJ. Food allergy and intolerance in IBS. J Gastroenterol Hepatol. 2007; 2:756-60.
  223. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML. Best of DDW 2007. Rev Gastroenterol Disor. 2007; 7(3):134-66.
  224. Talley NJ. The role of endoscopy in dyspepsia. ASGE Clinical Update. 2007; 15(1):1-4.
    View PubMed
  225. Kalantar JS, Talley NJ. Towards a diagnosis of functional dyspepsia. Med Today. 2007; 8(12):45-50.
    View PubMed
  226. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol. 2006 Dec; 101(12):2848-56; quiz 2914. Epub 2006 Oct 06.
    View PubMed
  227. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006 Nov; 36(11):724-8.
    View PubMed
  228. Cremonini F, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006 Nov; 18(11):987-94.
    View PubMed
  229. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006 Nov; 18(11):1001-8.
    View PubMed
  230. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol. 2006 Nov; 101(11):2449-52.
    View PubMed
  231. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol. 2006 Oct; 18(10):1101-9.
    View PubMed
  232. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24(5):859-67.
    View PubMed
  233. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug; 131(2):390-401; quiz 659-60.
    View PubMed
  234. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter. 2006 Aug; 11(4):224-30.
    View PubMed
  235. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):371-6.
    View PubMed
  236. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):405-10.
    View PubMed
  237. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 1; 24(1):55-63.
    View PubMed
  238. Chitkara DK, Bredenoord AJ, Talley NJ, Whitehead WE. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol. 2006 Jul; 9(4):305-13.
    View PubMed
  239. Talley NJ, Locke GR 3rd, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006 Jul; 55(7):933-9. Epub 2005 Dec 01.
    View PubMed
  240. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc) 2006 Jul; 42 Suppl B:3-8.
    View PubMed
  241. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006 Jun 24; 367(9528):2086-100.
    View PubMed
  242. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1725-33.
    View PubMed
  243. Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1749-55.
    View PubMed
  244. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, Stolte M, Talley NJ, Agreus L. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006 Jun 1; 163(11):1025-34. Epub 2006 Mar 22.
    View PubMed
  245. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol. 2006 Jun; 41(6):657-66.
    View PubMed
  246. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol. 2006 Jun; 101(6):1379-89.
    View PubMed
  247. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
    View PubMed
  248. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA. Best of DDW 2006. Rev Gastroenterol Disord. 2006 Summer; 6(3):153-89.
    View PubMed
  249. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D'Elia TV, Tack J, Earnest DL. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther. 2006 Apr 1; 23(7):923-36.
    View PubMed
  250. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1538-51.
    View PubMed
  251. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr; 101(4):701-10. Epub 2006 Feb 22.
    View PubMed
  252. Tally NJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation, and diagnosis... includes discussion. Advanced Studies in Medicine. 2006 Apr; 6(4A):S225-31, S251-3.
    View PubMed
  253. Talley NJ. How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Nat Clin Pract Gastroenterol Hepatol. 2006 Apr; 3(4):196-7.
    View PubMed
  254. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79.
    View PubMed
  255. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther. 2006 Mar 15; 23(6):683-90.
    View PubMed
  256. Talley NJ. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord. 2006 Spring; 6(2):72-8.
    View PubMed
  257. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006 Feb 23; 354(8):832-40.
    View PubMed
  258. Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol. 2006 Feb; 101(2):211.
    View PubMed
  259. Boyce PM, Talley NJ, Burke C, Koloski NA. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J. 2006 Jan; 36(1):28-36.
    View PubMed
  260. Fajardo NR, Wise JL, Locke GR 3rd, Murray JA, Talley NJ. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc. 2006 Jan; 63(1):184-5.
    View PubMed
  261. Hancox RJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, Cowan JO, Flannery EM, Herbison GP, Sears MR, Talley NJ. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res. 2006; 7:142. Epub 2006 Dec 05.
    View PubMed
  262. Stolte M, Muller H, Talley NJ, O'morain C, Bolling-Sternevald E, Sundin M, Eriksson S, Blum A. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. Pathol Res Pract. 2006; 202(6):405-13. Epub 2006 May 05.
    View PubMed
  263. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006; 295:1566-76.
  264. Talley NA, Talley NJ. Hepatitis C: diagnosis and management issues. Australian Defense Force Health. 2006; 7:22-8.
  265. Fajardo NR, Cremonini F, Talley NJ. Management of constipation in patients with cancer. Am J Cancer. 2006; 5(5):319-30.
    View PubMed
  266. Choung RS, Talley NJ. Food allergy and intolerance in IBS. Gastroenterol. Hepatol. 2006; 2(10):756-60.
    View PubMed
  267. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology. 2005 Dec; 129(6):1825-31.
    View PubMed
  268. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: A population-based case-control study. Am J Gastroenterol. 2005 Dec; 100(12):2743-8.
    View PubMed
  269. Talley N. Stop your intestines from rebelling. Bottom Line/Health. 2005 Dec; 19(12):5-6.
    View PubMed
  270. Talley NJ. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Disord. 2005 Winter; 5(1):1-9.
    View PubMed
  271. Yeomans ND, Lanas AI, Talley NJ, Thomson ABR, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005 Nov 1; 22(9):795-801.
    View PubMed
  272. Chitkara DK, Bredenoord AJ, Rucker MJ, Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther2005 Nov 1; 22(9):855-8.
    View PubMed
  273. Wise JL, Locke GR, Zinsmeister AR, Talley NJ. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther 2005 Nov; 22(10):1023-31.
    View PubMed
  274. Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1057-65.
    View PubMed
  275. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005 Nov; 129(5):1756-80.
    View PubMed
  276. Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005 Oct; 100(10):2324-37.
    View PubMed
  277. Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005 Oct; 54(10):1377-83.
    View PubMed
  278. Eslick GD, Coulshed DS, Talley NJ. Diagnosis and treatment of noncardiac chest pain. Nat Clin Pract Gastroenterol Hepatol. 2005 Oct; 2(10):463-72.
    View PubMed
  279. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: Birth-cohort study. Am J Gastroenterol. 2005 Sep; 100(9):2071-8.
    View PubMed
  280. Ahlawat SK, Richard Locke G, Weaver AL, Farmer SA, Yawn BP, Talley NJ. Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther. 2005 Aug 1; 22(3):251-9.
    View PubMed
  281. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep. 2005 Aug; 7(4):289-96.
    View PubMed
  282. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: A systematic review. Am J Gastroenterol. 2005 Aug; 100(8):1868-75.
    View PubMed
  283. Chitkara DK, Bredenood AJ, Wang M, Rucker MJ, Talley NJ. Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterol Motil. 2005 Aug; 17(4):518-22.
    View PubMed
  284. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289(2):G261-6.
    View PubMed
  285. Nandurkar S, Locke GR, Murray JA, Melton LJ, Zinsmeister AR, Dierkhising R, Talley NJ. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol. 2005 Jul; 100(7):1459-65.
    View PubMed
  286. Fawcett JP, Barbezat GO, Poulton R, Milne BJ, Xia HH, Talley NJ. Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol. 2005 Jun 7; 11(21):3273-6.
    View PubMed
  287. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005 Jun; 100(6):1226-32.
    View PubMed
  288. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005 Jun; 34(2):189-204.
    View PubMed
  289. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3(6):543-52.
    View PubMed
  290. Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJY, Langstrom G, Naesdal J, Scheiman JM. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol. 2005 May; 100(5):1028-36.
    View PubMed
  291. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol. 2005 Feb; 40(3):275-85.
    View PubMed
  292. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H-pylori infection: A report on histology and H-pylori detection in the general adult population. Scand J Gastroenterol. 2005 Feb; 40(3):302-11.
    View PubMed
  293. Cuddihy MT, Locke GR, Wahner-Roedler D, Dierkhising R, Zinsmeister AR, Long KH, Talley NJ. Dyspepsia management in primary care: a management trial. Int J Clin Pract. 2005 Feb; 59(2):194-201.
    View PubMed
  294. Locke GR, Zinsmeister AR, Fett SL, Melton LJ, Talley NJ. Overlap of gastrointestional symptom complexes in a US community. Neurogastroenterology & Motility. 2005 Feb; 17(1):29-34.
    View PubMed
  295. Kamm MA, Muller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005 Feb; 100(2):362-72.
    View PubMed
  296. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: An overview of available measures. Qual Life Res. 2005 Feb; 14(1):21-33.
    View PubMed
  297. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005 Feb; 2(2):82-8.
    View PubMed
  298. Koloski NA, Boyce PM, Talley NJ. Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci. 2005 Jan; 50(1):153-62.
    View PubMed
  299. Tuteja AK, Talley NJ, Joos SK, Woehl JV, Hickam DH. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol. 2005 Jan; 100(1):124-9.
    View PubMed
  300. Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: The role of other psychosocial variables. Digestion. 2005; 72(2-3):86-96.
    View PubMed
  301. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR 3rd, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study. Digestion. 2005; 72(2-3):97-103. Epub 2005 Sep 16.
    View PubMed
  302. Talley NJ. Environmental versus genetic risk factors for irritable bowel syndrome: clinical and therapeutic implications. Rev Gastroenterol Disord. 2005; 5(2):82-8.
    View PubMed
  303. Brandt LJ, Schoenfeld P, Prather CM, Quigley EMM, Schiller LR, Talley NJ. Evidence-based position statement on the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100(1 Suppl S):1-4.
    View PubMed
  304. Brandt LJ, Prather CM, Quigley EMM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100(1 Suppl S):S5-S22.
    View PubMed
  305. Halder SLS, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005; 8(4):325-36.
    View PubMed
  306. Talley NJ. Epidemiology, severity, and impact of irritable bowel syndrome. Pract Gastroenterol. 2005; 29(4 Suppl):4-12.
    View PubMed
  307. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, Junghard O, Johansson SE, Wiklund I, Agreus L. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol. 2004 Dec; 39(12):1201-8.
    View PubMed
  308. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004 Dec; 39(12):1280-8.
    View PubMed
  309. Vege SS, Locke GR 3rd, Weaver AL, Farmer SA, Melton LJ 3rd, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc. 2004 Dec; 79(12):1501-6.
    View PubMed
  310. Talley NJ. Management of chronic constipation. Reviews in Gastroenterological Disorders. 2004 Win; 4(1):18-24.
    View PubMed
  311. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA, Rentz AM, Dubois D. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004 Dec; 13(10):1751-62.
    View PubMed
  312. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004 Dec; 13(10):1737-49.
    View PubMed
  313. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome a tale of one or two disorders. Aliment Pharmacol Ther. 2004 Nov; 20(Suppl 7):40-9.
    View PubMed
  314. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology. 2004 Nov; 127(5):1329-37.
    View PubMed
  315. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Alimentary Pharmacology & Therapeutics. 2004 Oct 15; 20(8):909-15.
    View PubMed
  316. Crowell MD, Lacy BE, Schettler VA, Dineen TN, Olden KW, Talley NJ. Subtypes of anal incontinence associated with bowel dysfunction: Clinical, physiologic, and psychosocial characterization. Dis Colon Rectum. 2004 Oct; 47(10):1627-35.
    View PubMed
  317. Rohrbock RBK, Hammer J, Vogelsang H, Talley NJ, Hammer HF. Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: A study in health and IBS. Am J Gastroenterol. 2004 Oct; 99(10):1990-7.
    View PubMed
  318. Talley NJ. Practical examples: trials and conclusions - an interactive segment. Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):9-13.
    View PubMed
  319. Talley NJ. Gastro-oesophageal reflux disease - how wide is its span? Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):27-37.
    View PubMed
  320. Dent J, Talley NJ. Clinical strategies - interactive case discussions. Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):97-104.
    View PubMed
  321. Haag S, Talley NJ, Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut. 2004 Oct; 53(10):1445-51.
    View PubMed
  322. Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L, de Boer W, Jones R, Malfertheiner P, Agreus L. Management issues in dyspepsia: Current consensus and controversies. Scand J Gastroenterol. 2004 Oct; 39(10):913-8.
    View PubMed
  323. Cremonini F, Talley NJ. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Minerva Med. 2004 Oct; 95(5):427-41.
    View PubMed
  324. Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004 Sep 1; 20(5):497-505.
    View PubMed
  325. Friedrich WN, Whiteside SP, Talley NJ. Noncoercive sexual contact with similarly aged individuals: what is the impact? Journal of Interpersonal Violence. 2004 Sep; 19(9):1075-84.
    View PubMed
  326. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004 Sep; 99(9):1801-6.
    View PubMed
  327. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: A birth cohort study. Am J Gastroenterol. 2004 Sep; 99(9):1807-14.
    View PubMed
  328. Armstrong D, Talley NJ, Lauritsen K, Moum B, Lind T, Tunturi-Hihnala H, Venables T, Green J, Bigard MA, Mossner J, Junghard O. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics. 2004 Aug 15; 20(4):413-21.
    View PubMed
  329. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004 Aug; 16(4):413-9.
    View PubMed
  330. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004 Aug; 99(8):1572-8.
    View PubMed
  331. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol. 2004 Aug; 18(4):717-33.
    View PubMed
  332. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology & Therapeutics. 2004 Jul; 20(Suppl 2):23-30.
    View PubMed
  333. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004 May 1; 19(9):1025-31.
    View PubMed
  334. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004 May 1; 53(5):666-72.
    View PubMed
  335. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May; 13(4):833-44.
    View PubMed
  336. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004 May; 53(Suppl 4):1-24.
    View PubMed
  337. Holtmann G, Kutscher SU, Haag S, Langkafel M, Heuft G, Neufang-Hueber J, Goebell H, Senf W, Talley NJ. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - A randomized, double-blind placebo-controlled crossover study. Dig Dis Sci. 2004 Apr; 49(4):672-9.
    View PubMed
  338. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42.
    View PubMed
  339. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functioncal) dyspepsia. Gastroenterology. 2004 Apr; 126(4):971-9.
    View PubMed
  340. Locke GR 3rd, Murray JA, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc. 2004 Apr; 79(4):476-82.
    View PubMed
  341. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, Goh KL, Sollano J. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr; 19(4):357-67.
    View PubMed
  342. El-Serag HB, Talley NJ. Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54.
    View PubMed
  343. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: A population based nested case-control study. Am J Gastroenterol. 2004 Feb; 99(2):350-7.
    View PubMed
  344. Halder SLS, Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther. 2004 Jan 15; 19(2):233-42.
    View PubMed
  345. Eslick GD, Howell SC, Hammer J, Talley NJ. Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther. 2004 Jan 1; 19(1):133-40.
    View PubMed
  346. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs. 2004 Jan; 5(1):55-60.
    View PubMed
  347. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Reviews in Gastroenterological Disorders. 2004; 4(Suppl 2):S3-S10.
    View PubMed
  348. Talley NJ. Irritable bowel syndrome remains a difficult condition to manage. Drug Benefit Trends. 2004; 16(6):313-22.
    View PubMed
  349. Delgado-Aros S, Cremonini F, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2004; 7(2):121-31.
    View PubMed
  350. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. American Journal of Gastroenterology. 2004; 99:17081.
    View PubMed
  351. Talley NJ. Functional gastrointestinal disorders. DDW Reviews in Gastroenterological Disorders 2004 Review; 4:144-146.
    View PubMed
  352. Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, Diaz-Rubio M, Caldwell E, Cucala M, Fueyo A, Talley NJ. Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria. American Journal of Gastroenterology. 2004; 99:122-130.
    View PubMed
  353. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. American Journal of Medicine. 2004; 116:740-8.
    View PubMed
  354. De la Loge C, Trudeau E, Marquis P, Revicki D, Rentz AM, Stanghellini V, Talley NJ, Kahrilas P, Tack J, Dubois D. Responsiveness and interpretation of a quality of life questionnaire specific to upper-gastrointestinal disorders. Clinical Gastroenterology and Hepatology. 2004; 2:778-786.
    View PubMed
  355. Revicki DA, Rentz AM, Tack J, Stanghellini V, Talley NJ, Kahrilas P, de la Loge C, Trudeau E, Dubois D. Responsiveness and interpretation of the patient assessment of Gastrointestinal Symptom Severity Index (PAGI-SYM). Clinical Gastroenterology and Hepatology. 2004; 2:769-77.
    View PubMed
  356. Xia HHX, Wong BCY, Zhang GS, Yang Y, Wyatt JM, Adams S, Cheung K, Lam SK, Talley NJ. Antralization of gastric incisura is topographically associated with increased gastric epithelial apoptosis and proliferation, but not with CagA seropositivity. Journal of Gastroenterology & Hepatology. 2004; 19:1257-63.
    View PubMed
  357. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003 Dec 1; 52(12):1703-7.
    View PubMed
  358. Saito YA, Talley NJ, Melton LJ, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 Dec; 15(6):687-94.
    View PubMed
  359. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc. 2003 Nov; 58(5):661-70.
    View PubMed
  360. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003 Nov; 98(11):2454-9.
    View PubMed
  361. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol. 2003 Oct; 98(10):2209-18.
    View PubMed
  362. Talley NJ. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol. 2003 Oct; 56(4):362-9.
    View PubMed
  363. Talley NJ. Dyspepsia. Gastroenterology. 2003 Oct; 125(4):1219-26.
    View PubMed
  364. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Aug 15; 18(4):387-93.
    View PubMed
  365. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003 Jun 1; 17(11):1389-97.
    View PubMed
  366. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther. 2003 May 1; 17(9):1171-8.
    View PubMed
  367. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003 May; 98(5):1107-11.
    View PubMed
  368. Xia HHX, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM. Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):935-43.
    View PubMed
  369. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol. 2003 Apr; 98(4):750-8.
    View PubMed
  370. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol. 2003 Apr; 98(4):789-97.
    View PubMed
  371. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15000 Australian adults. Am J Gastroenterol. 2003 Feb; 98(2):391-8.
    View PubMed
  372. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003 Feb; 98(2):264-71.
    View PubMed
  373. Cremonini F, Talley NJ. Commentary – The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome by Creed F, Fernandes L, Guthrie E, et al. Br Med J. 2003; 8:160.
  374. Weltman M, Talley NJ. An approach to recurrent, non-identifiable GI bleeding. New Ethicals Journal. 2003; New Ethicals Journal. 2003:57-63.
  375. Talley NJ. Omeprazole was effective in the short term for uninvestigated dyspepsia ACP J Club. 2003; 138:1-3.
  376. Talley NJ. When to conduct testing in patients with suspected irritable bowel syndrome. Reviews in Gastroenterological Disorders. 2003; 3 Suppl 3:S18-24.
    View PubMed
  377. Müller-Lissner S, Koch G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, Lefkowitz M. Subject’s global assess (SGA) of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. Journal of Clinical Epidemiology. 2003; 56:310-16.
    View PubMed
  378. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting – a population-based study. Alimentary Pharmacology and Therapeutics. 2003; 17:1115-1124.
    View PubMed
  379. Quan C, Talley NJ, Cross S, Jones M, Hammer J, Giles N, Horowitz M. Development and validation of the diabetes bowel symptom questionnaire. Alimentary Pharmacology and Therapeutics. 2003; 17:1179-1187.
    View PubMed
  380. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index (GCSI). Alimentary Pharmacology and Therapeutics. 2003; 18:141-50.
    View PubMed
  381. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Alimentary Pharmacology and Therapeutics. 2003; 18:117-124.
    View PubMed
  382. Howell S, Poulton R, Caspi A, Talley NJ. Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study Journal of Psychosomatic Research. 2003; 55:179-87.
  383. Mearin F, Balboa A, Badia X, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. European Journal of Gastorenterology and Hepatology. 2003; 15:165-72.
  384. Talley NJ. Functional Disorders. Target the brain to get the gain? Reviews in Gastrointestinal Disorders. 2003; 3:182-4.
  385. Talley NJ. Best of DDW 2003. New insights on treatment of irritable bowel syndrome and functional dyspepsia Reviews in Gastroenterological Disorders. 2003; 3:172-5.
  386. Talley NJ. Update on the Role of Drug Therapy in Non-Ulcer Dyspepsia. Reviews in Gastroenterological Disorders. 2003; 3:25-30.
    View PubMed
  387. Wiklund I, Talley NJ. Update on health-related quality of life in patients with gastroesophageal reflux disease (GERD). Expert Rev Pharmacoeconomics & Outcomes Research. 2003; 3:341-50.
  388. Dent J, Talley NJ. Overview: initial and long-term management of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 2003; 1(17 Suppl):53-7.
  389. Weltman MD, Talley NJ. Chronic hepatitis C infection: a review and update on treatment strategies. ADF Health. 2003; 4:27-33.
  390. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobactor pylori eradication therapy in non-ulcer dyspepsia. Resolving the discrepancy between systematic reviews. American Journal of Gastroenterology. 2003; 98(12):2621-2626.
    View PubMed
  391. Talley NJ. Helicobacter pylori management: how to improve the therapeutic confusion in practice. Canadian Journal of Gastroenterology. 2003; B:21B-24B.
  392. Howe SC, Quine S, Talley NJ. Ethics review and use of reminder letters in postal surveys: are current practices comprising an evidence-based approach? Med J Aust. 2003; 178:43.
    View PubMed
  393. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology and Therapeutics. 2003; 17:841-51.
    View PubMed
  394. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2002 Dec; 97(12):3087-94.
    View PubMed
  395. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002 Dec; 97(12):2950-61.
    View PubMed
  396. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology. 2002 Dec; 123(6):1763-9.
    View PubMed
  397. Xia HH, Zhang GS, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002 Dec; 97(12):3023-31.
    View PubMed
  398. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology. 2002 Nov; 123(5):1451-8.
    View PubMed
  399. Talley NJ, Moore MG, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Med J Aust. 2002 Oct 21; 177(8):423-7.
    View PubMed
  400. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002 Oct; 47(10):2222-30.
    View PubMed
  401. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther. 2002 Sep; 16(9):1677-82.
    View PubMed
  402. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002 Sep; 16(9):1641-8.
    View PubMed
  403. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002 Sep; 97(9):2290-9.
    View PubMed
  404. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol. 2002 Aug; 14(8):857-63.
    View PubMed
  405. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol. 2002 Aug; 37(8):917-23.
    View PubMed
  406. Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res. 2002 May; 11(3):283-91.
    View PubMed
  407. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut. 2002 May; 50(Suppl 4):iv26-30; discussion iv31-2.
    View PubMed
  408. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002 May; 50(Suppl 4):iv72-8; discussion iv79.
    View PubMed
  409. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002 May; 50(Suppl 4):iv36-41.
    View PubMed
  410. Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci. 2002 Apr; 47(4):704-9.
    View PubMed
  411. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002 Mar; 97(3):604-11.
    View PubMed
  412. Kalantar JS, Howell S, Talley NJ. Prevalence of faecal incontinence and associated risk factors: an underdiagnosed problem in the Australian community? Med J Aust. 2002 Jan 21; 176(2):54-7.
    View PubMed
  413. Friedrich WN, Whiteside SP, Talley NJ. A research perspective on the compliant child victim. APSAC Advisor. 2002; 14(2):19-20.
    View PubMed
  414. Weltmann MD, Talley NJ. An approach to recurrent non-identifiable GI bleeding. Curr Ther. 2002; 43:27-35.
    View PubMed
  415. Coulshed DS, Eslick GD, Talley NJ. Non-cardiac chest pain: patients need diagnoses? Br Med J. 2002; 324:915.
    View PubMed
  416. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002; 20(11):749-58.
    View PubMed
  417. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002; 360:555-64.
    View PubMed
  418. Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology. 2002; 122:1521-5.
    View PubMed
  419. Eslick GD, Coulshed DS, Talley NJ. The burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther. 2002; 16:1217-23.
    View PubMed
  420. Talley NJ. Dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther. 2002; 16(Suppl 4):95-104.
    View PubMed
  421. Talley NJ, Quan C. Helicobacter pylori and non-ulcer dyspepsia. Aliment Pharmacol Ther. 2002; 16(Suppl 1):58-65.
    View PubMed
  422. Waldum HL, Brenna E, Alberti H, Jones R, Dent J, Kahrilas P, Talley NJ. Gastro-oesphageal reflux disease in general practice. Br Med J. 2002; 324:485.
  423. Axon A, Talley NJ, Veldhuyzen Van Zanten SJ. pH-Hp: implications for dyspepsia management. Gut. 2002; 50(Suppl 4):iv1.
    View PubMed
  424. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Practice of Clinical Gastroenterology. 2002; 16:63-76.
  425. Talley NJ, Abeygunasekera S. Bile reflux and Barrett's oesophagus: innocent bystander or sinister companion? Digestive and Liver Disease. 2002; 34:246-8.
    View PubMed
  426. Abeygunasekera S, Talley NJ. Management of dysepsia. Comprehensive Therapy. 2002; 28:182-9.
    View PubMed
  427. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother. 2002; 3:1301-11.
    View PubMed
  428. Jones R, Dent J, Kahrilas P, Talley NJ. Management of gastro-oesphageal reflux disease in general practice. Br Med J. 2002; 322:344-7.
  429. Talley NJ. Serotoninergic neuroenteric modulators. Lancet. 2001 Dec 15; 358(9298):2061-8.
    View PubMed
  430. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001 Dec; 46(12):2716-23.
    View PubMed
  431. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001 Nov; 36(11):1155-61.
    View PubMed
  432. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001 Oct; 96(10):2905-14.
    View PubMed
  433. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001 Oct; 121(4):799-804.
    View PubMed
  434. Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther. 2001 Oct; 15(10):1603-11.
    View PubMed
  435. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001 Sep 10; 161(16):1989-96.
    View PubMed
  436. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001 Sep; 49(3):395-401.
    View PubMed
  437. Talley NJ. Irritable bowel syndrome. Best Practice of Medicine. 2001 Sep.
  438. Talley NJ. Drug therapy options for patients with irritable bowel syndrome. Am J Manag Care. 2001 Jul; 7(8 Suppl):S261-7.
    View PubMed
  439. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001 Jul; 49(1):66-72.
    View PubMed
  440. Holtmann G, Gschossmann J, Holtmann M, Talley NJ. H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci. 2001 Jul; 46(7):1550-7.
    View PubMed
  441. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001 Jul; 96(7):1998-2004.
    View PubMed
  442. Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001 Jul; 15(7):981-7.
    View PubMed
  443. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia. Best Pract Res Clin Gastroenterol. 2001 Jun; 15(3):385-400.
    View PubMed
  444. Talley NJ, Thitiphuree S. Lump or split dyspepsia? A continuing controversy. Curr Gastroenterol Rep. 2001 Jun; 3(3):175-6.
    View PubMed
  445. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001 May 1; 134(9 Pt 2):815-22.
    View PubMed
  446. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001 May; 96(5):1422-8.
    View PubMed
  447. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May; 96(5):1340-9.
    View PubMed
  448. Talley SJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1033-8.
    View PubMed
  449. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol. 2001 Apr; 96(4):1139-42.
    View PubMed
  450. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001 Apr; 96(4):1072-9.
    View PubMed
  451. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, Kleoudis C, Mangel AW. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001 Apr; 15(4):525-37.
    View PubMed
  452. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1039-46.
    View PubMed
  453. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol. 2001 Mar; 96(3):673-6.
    View PubMed
  454. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar; 15(3):347-54.
    View PubMed
  455. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001 Mar; 96(3):689-96.
    View PubMed
  456. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Helicobacter pylori infection--current treatment practice. Expert Opin Pharmacother. 2001 Feb; 2(2):253-66.
    View PubMed
  457. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001 Feb; 15(2):207-16.
    View PubMed
  458. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M, Horowitz M. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001 Jan; 96(1):71-6.
    View PubMed
  459. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001 Jan; 96(1):52-7.
    View PubMed
  460. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001 Jan; 15(1):137-42.
    View PubMed
  461. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 2001 Jan; 96(1):16-26.
    View PubMed
  462. Dent J, Jones R, Kahrilas PJ, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. Br Med J. 2001; 322:344-47.
  463. Talley NJ. Commentary on "Community screening for Helicobacter pylori does not improve quality of life.". Evidence Based Healthcare. 2001; 5:7.
  464. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol. 2001; 96:673-6.
  465. Talley NJ. Metholdogical issues in irritable bowel syndrome clinical trials: practical relevance for the clinician. Practical Gastroenterology. 2001; 8:16-23.
  466. Talley NJ. Dealing with patients' concerns and expectations. Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S5-6.
  467. Talley NJ. Should oesophagitis be healed? Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S36-7.
  468. Talley NJ. Efficacies of different proton pump inhibitors in reflux disease. Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S55-6.
  469. Talley NJ. When and why should empirically treated patients have endoscopy? Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S75-6.
  470. Talley NJ, Phung N, Kalantar JS. ABC of the upper gastrointestinal tract: indigestion: when is it functional? Br Med J. 2001; 323:1294-7.
  471. Boyce P, Hickey A, Gilchrist J, Talley NJ. The development of a brief personality scale to measure vulnerability to postnatal depression. Archive of Women's Mental Health. 2001; 3:147-53.
  472. Bensoussan A, Chang SW, Menzies RG, Talley NJ. Application of the general health status questionnaire SF36 to patients with gastrointestinal dysfunction: initial validation and validation as a measure of change. Aust N Z J Public Health. 2001; 25(1):71-7.
    View PubMed
  473. Koloski NA, Talley NJ, Boyce PM, Morris-Yates AD. The effect of questionnaire length and lottery ticket incentive on the response rate in mail surveys. Psychology & Health. 2001; 16:67-75.
  474. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther. 2000 Dec; 14(12):1581-8.
    View PubMed
  475. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec; 14(12):1653-61.
    View PubMed
  476. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000 Nov 20; 173(10):515-9.
    View PubMed
  477. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 2000 Nov; 16(6):503-7.
    View PubMed
  478. Nandurkar S, Talley NJ. Epidemiology and natural history of reflux disease. Baillieres Best Pract Res Clin Gastroenterol. 2000 Oct; 14(5):743-57.
    View PubMed
  479. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000 Oct; 95(10):2816-24.
    View PubMed
  480. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000 Sep; 75(9):907-12.
    View PubMed
  481. Hu WH, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 2000 Sep; 95(9):2189-94.
    View PubMed
  482. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut. 2000 Sep; 47(3):332-6.
    View PubMed
  483. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol. 2000 Sep; 12(9):981-8.
    View PubMed
  484. Locke GR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol. 2000 Aug; 95(8):1906-13.
    View PubMed
  485. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000 Jun; 95(6):1439-47.
    View PubMed
  486. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000 May 26; 113(1110):178-81.
    View PubMed
  487. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther. 2000 May; 14(5):615-24.
    View PubMed
  488. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000 Apr; 95(4):878-96.
    View PubMed
  489. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci. 2000 Feb; 45(2):217-24.
    View PubMed
  490. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort and bowel habit descriptors. Scand J Gastroenterol. 2000 Feb; 35(2):142-51.
    View PubMed
  491. Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis. 2000 Feb; 36(2):69-74.
    View PubMed
  492. Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR. Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence Questionnaire. Dis Colon Rectum. 2000 Feb; 43(2):146-53; discussion 153-4.
    View PubMed
  493. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000 Jan; 95(1):67-71.
    View PubMed
  494. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, Mitchell HM. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol. 2000 Jan; 95(1):114-21.
    View PubMed
  495. Talley NJ. Diagnosis and management of non-ulcer dyspepsia. Primary Care Reports 6(1) 2000 Jan.
  496. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol. 2000 Jan; 95(1):157-65.
    View PubMed
  497. Pantoflickova D, Blum AL, Talley NJ, Koelz HR. Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Meta-analysis included unreliable studies. Br Med J. 2000; 320:1209.
    View PubMed
  498. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 2000; 95:3176-83.
    View PubMed
  499. Boyce P, Gilchrist J, Talley NJ, Rose D. Cognitive-behavioural therapy as a treatment for irritable bowel syndrome; a pilot study. Australian and New Zealand Journal of Psychiatry. 2000; 34:300-9.
    View PubMed
  500. Eslick GD, Talley NJ. Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust. 2000; 173:233-4.
    View PubMed
  501. Thitiphuree S, Talley NJ. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract. 2000; 54:537-41.
    View PubMed
  502. Talley NJ. Empirical eradication therapy was better than endoscopy-based management for Helicobacter pylori infection and dyspepsia. ACP Journal Club. 2000; 132:46.
  503. Westbrook JI, McIntosh JH, Talley NJ. The impact of dyspepsia definition on prevalence estimates: considerations for future researchers. Scand J Gastroenterol. 2000; 35:227-33.
    View PubMed
  504. Talley NJ. Irritable bowel syndrome: practical management. Aust Fam Physician. 2000; 29:893-8.
    View PubMed
  505. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 1999 Nov; 15(6):492.
    View PubMed
  506. Xia HH, Gallagher C, Hyde D, Talley NJ, Keane CT, O'Morain CA. Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. Ital J Gastroenterol Hepatol. 1999 Nov; 31(8):663-8.
    View PubMed
  507. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999 Nov; 52(11):1117-22.
    View PubMed
  508. van Zanten SJOV, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999 Sep; 45(Suppl 2):69-77.
  509. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999 Sep; 94(9):2390-7.
    View PubMed
  510. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999 Sep; 94(9):2373-9.
    View PubMed
  511. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol. 1999 Aug; 11(8):881-6.
    View PubMed
  512. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med. 1999 Jul 26; 159(14):1592-8.
    View PubMed
  513. Talley NJ. Gastro-esophageal reflux disease in adults. How to treat. Australian Doctor. 1999 Jul 2.
  514. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc. 1999 Jul; 47(7):837-41.
    View PubMed
  515. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999 Jun; 106(6):642-9.
    View PubMed
  516. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol. 1999 Jun; 34(6):566-74.
    View PubMed
  517. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J. 1999 Mar 27; 318(7187):833-7.
  518. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999 Feb; 13(2):225-35.
    View PubMed
  519. Bolin TD, Korman MG, Stanton R, Talley NJ, Newstead GL, Donnelly N, Hall W, Ho MT, Lapsley H. Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal Disease. 1999; 1:113-22.
  520. Lam CM, Kennedy ML, Lubowski DZ, Talley NJ. Prevalence and risk factors for faecal incontinence: a population based study. Colorectal Disease. 1999; 1:197-203.
  521. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med. 1999; 341:1106-11.
    View PubMed
  522. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Clinical Gastroenterology International Practice and Research. 1999; 13:371-84.
  523. Xia HH, Talley NJ. Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs. 1999; 58:785-92.
    View PubMed
  524. Xia HH, Fan X-G, Talley NJ. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World Journal of Gastroenterology. 1999; 5:263-6.
    View PubMed
  525. Talley NJ, Axon A, Bytzer P, Holtmann G, Lam SK, Veldhuyzen van Zanten S. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther. 1999; 13:1135-48.
    View PubMed
  526. Talley NJ. How should Helicobacter pylori positive dyspeptic patients be managed? Gut. 1999; 45(Suppl 1):I28-31.
    View PubMed
  527. Nandurkar S, Talley NJ. Barrett's esophagus: the long and the short of it. Am J Gastroenterol. 1999; 94:1719.
    View PubMed
  528. Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med. 1999; 107(Suppl 5A):5S-11S.
    View PubMed
  529. Talley NJ. Management of dyspepsia and functional dyspepsia: an international perspective. Canadian Journal of Gastroenterology. 1999; 13:685-7.
    View PubMed
  530. Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointestinal Endoscopy. 1999; 50:229-40.
    View PubMed
  531. Tytgat G, Hungin APS, Malfertheiner P, Talley NJ, Hongo M, McColl K, Soule JC, Agreus L, Bianchi-Porro G, Freston J, Hunt R. Decision making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol. 1999; 11:223-30.
    View PubMed
  532. Talley NJ, Stanghellini V, Heading R, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders: a working team report for the Rome II consensus on funtional gastrointestinal disorders. Gut. 1999; 45(Suppl 2):II37-42.
    View PubMed
  533. Talley NJ, Wingate DL. Irritable bowel syndrome and the role of 5-HT. Aliment Pharmacol Ther. 1999; 13(Suppl 2):1-82.
  534. Talley NJ. Helicobacter pylori and dyspepsia. Yale Journal of Biology and Medicine. 1999; 72:145-51.
    View PubMed
  535. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ. An evidence-based appraisal of reflux disease management: the Genval workshop report. Gut. 1999; 44(Suppl 2):S1-S16.
    View PubMed
  536. Kalantar J, Eslick G, Talley NJ. Chronic gastritis and non-ulcer dyspepsia. Curr Top Microbiol Immunol. 1999; 241:31-45.
    View PubMed
  537. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 1.
  538. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 2.
  539. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 3.
  540. Yeomans N, Talley NJ, Lee A, Katelaris P. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute. 1999.
  541. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med. 1998 Dec 24; 339(26):1875-81.
    View PubMed
  542. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1585-9.
    View PubMed
  543. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec. 1998 Nov; 252(3):418-25.
    View PubMed
  544. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998 Nov; 12(11):1067-78.
    View PubMed
  545. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov; 12(11):1055-65.
    View PubMed
  546. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol. 1998 Nov; 93(11):2179-83.
    View PubMed
  547. Xia HH, Kalantar J, Talley NJ. Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in Western Sydney as determined by testing multiple isolates from different gastric sites. J Gastroenterol Hepatol. 1998 Oct; 13(10):1044-9.
    View PubMed
  548. Nandurkar S, Martin CJ, Talley NJ, Wyatt JM. Curable cancer in a short segment Barrett's esophagus. Dis Esophagus. 1998 Oct; 11(4):284-7.
    View PubMed
  549. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998 Aug; 93(8):1271-6.
    View PubMed
  550. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998 Aug; 93(8):1311-7.
    View PubMed
  551. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer, and health. Am J Gastroenterol. 1998 Aug; 93(8):1222-7.
    View PubMed
  552. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not Helicobacter pylori. Arch Intern Med. 1998 Jul 13; 158(13):1427-33.
    View PubMed
  553. Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther. 1998 Jul; 12(7):641-5.
    View PubMed
  554. Talley NJ, Chang FY, Wyatt JM, Adams S, Lau A, Borody T, Chen TS, Daskolopolos G, Cheung K, Talley NA, Full-Young C, Tseng-Shing C. Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jun; 12(6):527-32.
    View PubMed
  555. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc. 1998 Jun; 47(6):449-54.
    View PubMed
  556. Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci. 1998 May; 43(5):1016-22.
    View PubMed
  557. Talley NJ, Boyce P, Jones M. Identification of distrinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998 May; 42(5):690-5.
    View PubMed
  558. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998 Apr; 42(4):501-6.
    View PubMed
  559. Roberts RO, Jacobsen SJ, Rhodes T, Reilly WT, Girman CJ, Talley NJ, Lieber MM. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc. 1998 Apr; 46(4):467-72.
    View PubMed
  560. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology. 1998 Feb; 51(2):213-9.
    View PubMed
  561. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population-based study. Gut. 1998 Jan; 42(1):47-53.
    View PubMed
  562. Evans JM, Fleming KC, Talley NJ, Schleck CD, Zinsmeister AR, Melton LJ III. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc. 1998 Jan; 46(1):83-7.
    View PubMed
  563. Junghard O, Lauritsen K, Talley NJ, Wiklund IK. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia. Eur J Surg Suppl. 1998; 583:106-11.
    View PubMed
  564. Talley NJ, Eslick GD. Commentary on "Eradication of Helicobacter pylori before NSAID treatment prevented ulcers.". ACP Journal Club. 1998; 128:44.
  565. Talley NJ. Commentary on review: Misoprostol was most cost-effective if risk for NSAID-related GI events was high. Arthritis Rheum. 1998; 129:25.
  566. Nandurkar S, Talley NJ. Surveillance in Barrett's esophagus: a need for reassessment? J Gastroenterol Hepatol. 1998; 13:1069-105.
    View PubMed
  567. Talley NJ, Hau-Xiang Xia H. Helicobacter pylori infection and non-ulcer dyspepsia. British Medical Bulletin. 1998; 54:63-9.
    View PubMed
  568. Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998; 93:394-400.
    View PubMed
  569. Veldhuyzen van Zanten S, Talley NJ. Should antibiotic treatment of Helicobacter positive patients within non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol. 1998; 10:367-70.
    View PubMed
  570. Hu WHC, Talley NJ. Functional (non-ulcer) dyspepsia: unexplained but not unmanageable. Med J Aust. 1998; 168:507-12.
    View PubMed
  571. Talley NJ. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Am J Med. 1998; 104:S62-6.
    View PubMed
  572. Talley NJ. Scope of the problem of functional digestive disorders. European Journal of Surgery. 1998; 164(Suppl 582):135-41.
  573. Talley NJ. Irritable bowel syndrome: disease definition and symptom description. Eur J Surg. 1998; 164(Suppl 583):24-8.
  574. Talley NJ, Silverstein M, Agreus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review-evaluation of dyspepsia. Gastroenterology. 1998; 114:582-95.
    View PubMed
  575. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus guidelines on the management of H. pylori. J Gastroenterol Hepatol. 1998; 13:1-12.
    View PubMed
  576. Hammer J, Talley NJ. Non-ulcer dyspepsia: evaluation (including the role of Helicobacter pylori, the role of dysmotility, and management). Curr Opin Gastroenterol. 1998; 14:447-51.
  577. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol. 1998; 93:2184-90.
    View PubMed
  578. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998; (583):41-9.
  579. Phung N, Kalantar J, Talley NJ. Management of dyspepsia in general practice. Mod Med. 1998; 41:10-18.
  580. Talley NJ, O'Connor S. Sistema nervioso: exploracion de los nervios craneales (III). Review Salud Rural. 1998; 5:111-30.
  581. Talley NJ, Kalantar JS. Unexplained weight loss. Curr Ther. 1998; 37-43.
  582. Holtmann G, Stanghellini V, Talley NJ. Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. Baillieres Clin Gastroenterol. 1998; 12:417-33.
    View PubMed
  583. Weltmann M, Talley NJ. The patient with recurrent non-identifiable GI bleeding. Current Therapeutics. 1998.
  584. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci. 1997 Nov; 42(11):2327-32.
    View PubMed
  585. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut. 1997 Sep; 41(3):394-8.
    View PubMed
  586. Talley NA, Chen F, King D, Jones M, Talley NJ. Short chain fatty acids in the treatment of radiation proctitis: a randomized, placebo-controlled crossover trial. Dis Colon Rectum. 1997 Sep; 40(9):1046-50.
    View PubMed
  587. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis, and associations. Gut. 1997 Jun; 40(6):710-5.
    View PubMed
  588. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol. 1997 Jun; 92(6):954-9.
    View PubMed
  589. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997 May; 112(5):1448-56.
    View PubMed
  590. Friedrich WN, Talley NJ, Panser L, Fett S, Zinsmeister AR. Concordance of reports of childhood abuse by adults. Child Maltreat. 1997 May; 2(2):164-71.
  591. Frankum B, Talley NJ. The tired listless patient. Curr Ther. 1997 Mar; 41-5.
  592. Talley NJ, Xia HH. Gastric cancer. An infectious disease? New Zealand Patient Management. 1997; 26:9-11.
  593. Agreus L, Talley NJ. Dyspepsia: current understanding and management. Annual Review Medicine. 1997; 49:475-93.
  594. Agreus L, Talley N. Dyspepsia management in general practice. Br Med J. 1997; 315:1284-8.
  595. McManis PG, Talley NJ. Nausea and vomiting associated with selective serotonin reuptake inhibitors: incidence, mechanisms, and management. CNS Drugs. 1997; 8:394-401.
  596. Xia HH, Talley NJ, Keane CT, O'Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature, possible causes, and potential preventive strategies. Dig Dis Sci. 1997; 42:1821-34.
    View PubMed
  597. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol. 1997; 92:1780-7.
    View PubMed
  598. Talley NJ, Hunt RH. What role does Helicobacter pylori play in non-ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms Gastroenterology. 1997; 113(6 Suppl S):S67-77.
  599. Talley NJ. Dyspepsia and heartburn: a clinical challenge. Aliment Pharmacol Ther. 1997; 11(Suppl 2):1-8.
  600. Holtmann G, Talley NJ, Goebell H. Association between Helicobacter pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci. 1996 Jul; 41(7):1285-91.
    View PubMed
  601. Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol. 1996 Jun; 91(6):1138-44.
    View PubMed
  602. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Am J Gastroenterol. 1996 Apr; 91(4):660-73.
    View PubMed
  603. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol. 1996 Mar; 91(3):485-91.
    View PubMed
  604. Talley NJ, Hu WHC. Commentary on "Misoprostol reduced serious NSAID-induced gastrointestinal complications in rheumatoid arthritis.". Ann Intern Med. 1996 Mar-Apr; 124:38.
  605. Toma TP, Zighelboim J, Phillips SF, Talley NJ. Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat. Neurogastroenterol Motil. 1996 Mar; 8(1):19-28.
    View PubMed
  606. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996 Feb; 91(2):277-83.
    View PubMed
  607. Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, Melton LJ. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996 Jan; 91(1):19-25.
    View PubMed
  608. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996 Jan; 110(1):72-83.
    View PubMed
  609. Talley NJ. Modern management of dyspepsia. Aust Fam Physician. 1996; 25:47-52.
    View PubMed
  610. Hu WHC, Talley NJ. Visceral perception in functional gastrointestinal disorders: disease marker or epiphenomenon? Dig Dis. 1996; 4:276-88.
  611. Talley NJ. Quality of life in functional dyspepsia. Scand J Gastroenterol. 1996; 31(Suppl 221):21-2.
  612. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol. 1996; 31(Suppl 220):19-22.
  613. Xia HH, Talley NJ. Prospects for improved therapy for Helicobacter pylori. (Leading Article). Expert Opin Investig Drugs. 1996; 5:959-76.
  614. Talley NJ. H. pylori and functional dyspepsia. Excepta Medica. 1996; 5-6.
  615. Talley NJ. Helicobacter pylori: a role in functional dyspepsia? Motility Clinical Perspective in Gastroenterology. 1996; 34:11-12.
  616. Talley NJ. The irritable bowel syndrome: the guts of the problem. Resident & Staff Physician. 1996; 42:11-16.
  617. Talley NJ. Management of peptic ulcer disease. No role for long-term H2RAs. Gastrointestinal Medicine in General Practice. 1996; 8:22-5.
  618. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican. 1996; 14:7-13.
  619. Talley NJ. Is there a role for H2 -receptor blockers in the treatment of H. pylori gastritis? The Management of Acid Peptic Disorders: An Asian Perspective. 1996; 12:25-9.
  620. Talley NJ. Irritable bowel syndrome. Australian Doctor. 1996.
  621. Locke GR III, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology. 1995 Dec; 109(6):1750-6.
    View PubMed
  622. Talley NJ, Hu WHC, Holtmann G. Symptoms, investigation and treatment of gastroparesis. Mod Med Aust. 1995 Dec; 27-33.
  623. Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995 Dec; 90(12):2115-9.
    View PubMed
  624. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995 Nov 15; 123(10):782-94.
    View PubMed
  625. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med. 1995 Aug; 25(4):302-8.
    View PubMed
  626. Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995 Jul 1; 142(1):76-83.
    View PubMed
  627. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995 Jul; 50(4):M184-9.
    View PubMed
  628. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995 Jun; 40(6):1345-50.
    View PubMed
  629. Talley NJ, Hu WHC. Commentary on "Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.". Ann Intern Med. 1995 May-Jun; 122:81.
  630. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995 Apr; 40(4):819-27.
    View PubMed
  631. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol. 1995 Mar; 90(3):366-71.
    View PubMed
  632. Talley NJ, Weaver AL, Zinsmeister AR. Impact on functional dyspepsia on quality of life. Dig Dis Sci. 1995 Mar; 40:584-589.
    View PubMed
  633. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995 Mar; 108(3):917-24.
    View PubMed
  634. Talley NJ. Dyspepsia in the elderly. Mod Med Aust. 1995 Feb; 72-6.
  635. Owens DM, Nelson DK, Talley NJ. Irritable bowel syndrome: long term prognosis and the physician-patient interaction. Ann Intern Med. 1995 Jan 15; 122(2):107-12.
    View PubMed
  636. Zighelboim J, MacCarty RL, Talley NJ. Abnormalities in the shape of the duodenal loop on X-ray. Associated with idiopathic antral hypomotility? Dig Dis Sci. 1995 Jan; 40(1):128-33.
    View PubMed
  637. Holtmann G, Guerra G, Huber J, Goebell H, Talley NJ. Perception of gastric distention: influence of the mode of distention on perception thresholds and gastric compliance. Dig Dis Sci. 1995; 40:2673-7.
    View PubMed
  638. Bolin T, Hunt R, Korman M, Lambert J, Lee A, Talley NJ. Helicobacter pylori and gastric neoplasia: evolving concepts. Med J Aust. 1995; 163:253-25.
    View PubMed
  639. Talley NJ. Functional dyspepsia: should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther. 1995; 9:107-15.
    View PubMed
  640. Talley NJ. Management of dyspepsia. Gastrointestinal Diseases Today. 1995; 4:11-17.
  641. Lambert J, Lee A, Talley NJ, Yeomans N. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute. 1995.
  642. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994 Oct; 107(4):1040-9.
    View PubMed
  643. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994 Aug; 89(8):1160-4.
    View PubMed
  644. Zighelboim J, Talley NJ, Phillips SF. Response of gastric fundus to rectal distension in healthy persons. Dig Dis Sci. 1994 Jul; 39(7):1441-5.
    View PubMed
  645. Grotz RL, Pemberton JH, Talley NJ, Rath DM, Zinsmeister AR. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut. 1994 Jun; 35(6):798-802.
    View PubMed
  646. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ III. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994 Jun; 89(6):843-6.
    View PubMed
  647. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun; 69(6):539-47.
    View PubMed
  648. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994 May; 35(5):619-24.
    View PubMed
  649. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Curr Ther. 1994 May; 55-63.
  650. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May; 106(5):1174-83.
    View PubMed
  651. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994 May; 39(5):1090-8.
    View PubMed
  652. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994 Apr; 89(4):524-8.
    View PubMed
  653. Talley NJ. Epidemiology of Helicobacter pylori infection. NIH Consens Statement. 1994 Feb 7-9; 12:1-15.
  654. Talley NJ. A relationship between Helicobacter pylori and non-ulcer dyspepsia: is there enough data to know? Eur J Gastroenterol Hepatol. 1994; 6:567-70.
  655. Talley NJ. Commentary on "Prompt endoscopy was more cost-effective than H2-blockers in dyspepsia.". Ann Intern Med. 1994; 121(Suppl 2).
  656. Talley NJ. Gastroduodenal motility. Curr Opin Gastroenterol. 1994; 10:618-22.
  657. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. European Journal of Gastroenterology and Hepatology. 1994; 6:917-24.
  658. Talley NJ. Diagnosis of Helicobacter pylori infection. Infections in Medicine. 1994; (Special Supplement):18-26.
  659. Talley NJ. Food for thought: the real story behind stomach ulcers. Chem Ind. 1994; 7:259-62.
  660. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993 Nov; 68(11):1067-73.
    View PubMed
  661. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993 Nov; 105:1378-1386.
    View PubMed
  662. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther. 1993 Oct; 7(5):543-51.
    View PubMed
  663. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep; 105(3):781-90.
    View PubMed
  664. Zighelboim J, Carpenter HA, Talley NJ. A patient with diarrhea, arthralgias, and fever. Gastroenterology. 1993 Sep; 105(3):923-30.
    View PubMed
  665. Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs. 1993 Jun; 45(6):918-30.
    View PubMed
  666. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993 May; 104(5):1310-9.
    View PubMed
  667. Locke GR, Talley NJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol. 1993 May-Jun; 8(3):279-86.
    View PubMed
  668. Talley NJ. Non-ulcer dyspepisa: current approaches to diagnosis and management. Am Fam Physician 1 1993 May; 47(6):1407-16.
  669. Zighelboim J, Talley NJ. Viewpoints in digestive diseases: what are functional bowel disorders? Gastroenterology. 1993 Apr; 104(4):1196-201.
    View PubMed
  670. Talley NJ. The role of Helicobacter pylori in non-ulcer dyspepsia. Gastroenterol Clin North Am. 1993 Mar; 22:153-67.
    View PubMed
  671. Talley NJ, Kramlinger KG, Burton MC, Colwell LJ, Zinsmeister AR. Psychiatric disorders and childhood abuse in the irritable bowel syndrome. Eur J Gastroenterol Hepatol. 1993; 5:647-54.
  672. Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF. The irritable bowel syndrome: toward optimal design of controlled treatment trials. Gastroenterology International. 1993; 6:189-211.
  673. Talley NJ. Commentations on "Cholecystectomy and the risk for colorectal cancer.". Ann Intern Med. 1993; 120(Suppl 1).
  674. Thomas DW, Talley NJ, Mahnovski V, Haight M, Sinatra FR. Rectal mucosal major basic protein in infants with dietary protein-induced colitis. Annals of Allergy. 1993; 71:66-9.
    View PubMed
  675. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993; 38:1569-80.
    View PubMed
  676. Talley NJ. Non-steroidal anti-inflammatory drug-induced gatroduodenopathy. Dear Colleague. 1993.
  677. Talley NJ. The effects of NSAIDs on the gut. Contemp Intern Med. 1993; 5:14-28.
  678. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med. 1992 Dec 31; 327(27):1919-23.
    View PubMed
  679. Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec; 30(12):3146-50.
    View PubMed
  680. Talley NJ. Symptom patterns in functional dyspepsia. Eur J Gastroenterol Hepatol. 1992 Aug; 4:597-601.
  681. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67(8):725-31.
    View PubMed
  682. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc. 1992 Aug; 67(8):732-8.
    View PubMed
  683. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 1992 Jul 15; 136(2):165-77.
    View PubMed
  684. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992 Jul; 47(4):M116-21.
    View PubMed
  685. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 1992 Jul; 103(1):137-45.
    View PubMed
  686. Talley NJ. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther. 1992 Jun; 6(3):273-89.
    View PubMed
  687. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992 Jun; 102(6):1899-905.
    View PubMed
  688. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health. Am J Gastroenterol. 1992 May; 87(5):590-4.
    View PubMed
  689. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr; 102(4 Pt 1):1259-68.
    View PubMed
  690. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc. 1992 Apr; 67(4):354-64.
    View PubMed
  691. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33(4):541-6.
    View PubMed
  692. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar; 102:895-901.
    View PubMed
  693. Talley NJ. Dyspepsia and functional dyspepsia. Clin Perspect Gastroenterol. 1992; 20:4-8.
  694. Talley NJ. Helicobacter pylori infection. Decision Making in GI Disease. 1992; 5:1-8.
  695. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4; 83(23):1734-9.
    View PubMed
  696. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991 Oct; 101(4):927-34.
    View PubMed
  697. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol. 1991 Aug; 29(8):1635-9.
    View PubMed
  698. O'Keefe E, Talley NJ. The irritable bowel syndrome in the elderly. Gastroenterol Clin North Am. 1991 Jun; 20:369-90.
  699. O'Keefe E, Talley NJ. Irritable bowel syndrome in the elderly. Clin Geriatr Med. 1991 May; 7(2):265-86.
    View PubMed
  700. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci. 1991 Apr; 36(4):435-40.
    View PubMed
  701. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 1991 Feb; 36:142-145.
    View PubMed
  702. Fich A, Talley NJ, Shorter RG, Phillips SF. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion. Dig Dis Sci. 1991 Jan; 36(1):10-4.
    View PubMed
  703. Talley NJ, Phillips SF, Bruce BK, Zinsmeister AR, Wiltgen C, Melton LJ. Multisystem complaints in patients with the irritable bowel syndrome and functional dyspepsia. Eur J Gastroenterol Hepatol. 1991 Jan; 3:71-77.
  704. Myers MB, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking cardinoid syndrome. Am J Med. 1991; 90:646-648.
    View PubMed
  705. Smith RC, Talley NJ, Dent OF, Jones M, Waller SL. Exocrine pancreatic function and chronic unexplained dyspepsia. A case control study. International Journal of Pancreatology. 1991; 8:253-62.
    View PubMed
  706. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International. 1991; 4:145-60.
  707. Tygat GNJ, Heading RC, Knill-Jones RP, Richter JE, Malagelada JR, Nyren O, Talley NJ. Towards understanding dyspepsia: an update and consensus from an international working party. Scand J Gastroenterol. 1991; 26(Suppl 182):1-74.
  708. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol. 1991; 26(Suppl 182):47-60.
  709. Talley NJ. Spectrum of chronic dyspepsia in the prescence of the irritable bowel syndrome. Scand J Gastroenterol. 1991; 26(Suppl 182):7-10.
  710. Talley NJ. Non-ulcer dyspepsia: myths and realities. Aliment Pharmacol Ther. 1991; 5 (Suppl 1):145-62.
    View PubMed
  711. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International. 1990 Dec; 3:159-172.
  712. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov; 65(11):1456-79.
    View PubMed
  713. Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology. 1990 Aug; 99(2):327-33.
    View PubMed
  714. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci. 1990 Jul; 35(7):879-84.
    View PubMed
  715. MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol. 1990 Summer; 15(3):183-7.
    View PubMed
  716. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci. 1990 Apr; 35(4):477-80.
    View PubMed
  717. Ormand JE, Talley NJ. Helicobacter pylori: controversies and an approach to management. Mayo Clin Proc. 1990 Mar; 65(3):414-26.
    View PubMed
  718. Fich A, Talley NJ, Shorter RG, Phillips SF. Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc. 1990 Feb; 65(2):187-91.
    View PubMed
  719. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990 Jan; 31(1):77-81.
    View PubMed
  720. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990 Jan; 31(1):54-8.
    View PubMed
  721. Pym B, Sandstad J, Seville P, Byth K, Middleton WRJ, Talley NJ, Piper DW. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology. 1990; 99:27-35.
    View PubMed
  722. Talley NJ. A practical approach to dyspepsia. Contemp Intern Med. 1990; 25-33.
  723. Talley NJ. Helicobacter pylori and chronic gastroduodenal disease. Infectious Diseases Newsletter. 1990; 9:65-7.
  724. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ 3rd. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med. 1989 Nov 1; 111(9):738-42.
    View PubMed
  725. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15; 111(8):671-4.
    View PubMed
  726. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, Ciociola A. Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides. Dig Dis Sci. 1989 Oct; 34(10):1511-5.
    View PubMed
  727. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97(3):775-7.
    View PubMed
  728. Talley NJ. Chronic (nonerosive) gastritis: pathogenesis and management. Dig Dis. 1989; 7(2):61-75.
    View PubMed
  729. Talley NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW. Lack of association between gastric emptying of solids and symptoms in non-ulcer dyspepsia. J Clin Gastroenterol. 1989; 11:625-30.
    View PubMed
  730. Ormand JE, Talley NJ. Campylobacter pylori, mucus, and peptic ulceration: a dynamic interaction. J Clin Gastroenterol. 1989; 11:492-5.
    View PubMed
  731. Talley NJ, Ormand JE. Is antibacterial therapy against Campylobacter pylori useful in the therapy of indigestion and chronic peptic ulceration? Trends in Pharmacological Sciences. 1989; 10:36-40.
    View PubMed
  732. Talley NJ, Kellow JE, Piper DW. Non-ulcer dyspepsia: a management plan. Curr Ther. 1989; 30:91-103.
  733. Talley NJ. Upper gastrointestinal distress: guidelines for empirical treatment and investigation. Med Times. 1989; 117:25-8.
  734. Talley NJ. Campylobacter pylori and chronic peptic ulceration: do bugs cause ulcers? Asociacion de Medicina Interna de Mexico, AC. Clinicas Medicas Mexicanas. Curso Internacional de Medicina Interna. 1989; 3:5-7.
  735. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc. 1988 Dec; 63(12):1176-80.
    View PubMed
  736. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med. 1988 Jun; 108(6):865-79.
    View PubMed
  737. Talley NJ, Jones M, Piper DW. Psychosocial and childhood factors in essential dyspepsia. A case control study. Scand J Gastroenterol. 1988; 23:341-6.
    View PubMed
  738. Talley NJ, McNeil D, Piper DW. Environmental factors and chronic unexplained dyspepsia: association with acetaminophen but not other analgesics, alcohol, coffee, tea, or smoking. Digestive Diseases and Sciences. 1988; 33:641-8.
    View PubMed
  739. Talley NJ, Ellard K, Jones M, Tennant C, Piper DW. Suppression of emotions in essential dyspepsia and chronic duodenal ulcer: a case control study. Scand J Gastroenterol. 1988; 23:337-40.
    View PubMed
  740. Talley NJ, Eckstein RP, Gattas MR, Stiel D. Acute hepatitis and Brucella melitensis infection: clinicopathological findings. Medical Journal of Australia. 1988; 148:587-90.
    View PubMed
  741. Talley NJ, Roth A, Woods J, Hench V. Diagnostic value of liver biopsy in alcoholic liver disease. Journal of Clinical Gastroenterology. 1988; 10:647-50.
    View PubMed
  742. Talley NJ, McNeil D, Hayden A, Colreavy C, Piper DW. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed non-ulcer dyspepsia. Gastroenterology. 1987; 92:1060-6.
    View PubMed
  743. Talley NJ, McNeil D, Piper DW. Discriminant value of dyspeptic symptoms. A study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut. 1987; 28:40-6.
    View PubMed
  744. Talley NJ, Piper DW. A prospective study of social factors and major life event stress in patients with dyspepsia of unknown cause. Scand J Gastroenterol. 1987; 22:268-72.
    View PubMed
  745. Talley NJ. Non-ulcer dyspepsia. Medical Progress. 1987; 31-41.
  746. Talley NJ. Non-ulcer dyspepsia: what measures help? Curr Ther. 1986; 27:81-97.
  747. Talley NJ. Are symptoms really useful in diagnosing the cause of dyspepsia? Mod Med Aust. 1986; 29-31.
  748. Piper DW, Talley NJ, Ellard K. Long-term (maintenance) treatment of chronic peptic ulcer. Mod Med Aust. 1986; 18-21.
  749. Talley NJ, Piper DW. Comparison of the clincial features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease. Australian and New Zealand Journal of Medicine. 1986; 16:352-9.
    View PubMed
  750. Talley NJ, Piper DW. Major life event stress and dyspepsia of unknown cause: a case control study. Gut. 1986; 27:127-34.
    View PubMed
  751. Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology. 1986; 91:149-56.
    View PubMed
  752. Talley NJ, Fung LH, Gilligan IJ, McNeil D, Piper DW. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case control study. Gastroenterology. 1986; 90:886-92.
    View PubMed
  753. Fung LH, Gilligan IJ, Talley NJ, Piper DW. Chronic duodenal ulcer, marital status, and personality pattern: a case control study. Journal of Gastroenterology and Hepatology. 1986; 1:251-6.
  754. Talley NJ. Dyspepsia and non-ulcer dyspepsia: an historical perspective. Med J Aust. 1986; 145:614-8.
    View PubMed
  755. Talley NJ, Piper DW. The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scandinavian Journal of Gastroenterology. 1985; 20:896-900.
    View PubMed
  756. Palmer FJ, Talley NJ. Erdheim-Chester disease with bilateral exophthalmus and liver cell adenoma. Australasian Radiology. 1984; 28:305-10.
    View PubMed